Jiang Chenlu, Zhao Jiacheng, Zhang Yihang, Zhu Xiang
Department of Anesthesiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Medical School of Nantong University, Nantong, 226001, China.
Biochem Biophys Rep. 2024 Jan 22;37:101645. doi: 10.1016/j.bbrep.2024.101645. eCollection 2024 Mar.
Chronic pain usually lasts over three months and commonly occurs in chronic diseases (cancer, arthritis, and diabetes), injuries (herniated discs, torn ligaments), and many major pain disorders (neuropathic pain, fibromyalgia, chronic headaches). Unfortunately, there is currently a lack of effective treatments to help people with chronic pain to achieve complete relief. Therefore,it is particularly important to understand the mechanism of chronic pain and find new therapeutic targets. The exchange protein directly activated by cyclic adenosine monophosphate(cAMP) (EPAC) has been recognized for its functions in nerve regeneration, stimulating insulin release, controlling vascular pressure, and controlling other metabolic activities. In recent years, many studies have found that the subtype of EPAC, EPAC1 is involved in the regulation of neuroinflammation and plays a crucial role in the regulation of pain, which is expected to become a new therapeutic target for chronic pain. This article reviews the major contributions of EPAC1 in chronic pain.
慢性疼痛通常持续超过三个月,常见于慢性疾病(癌症、关节炎和糖尿病)、损伤(椎间盘突出、韧带撕裂)以及许多主要的疼痛病症(神经性疼痛、纤维肌痛、慢性头痛)。不幸的是,目前缺乏有效的治疗方法来帮助慢性疼痛患者实现完全缓解。因此,了解慢性疼痛的机制并找到新的治疗靶点尤为重要。环磷酸腺苷(cAMP)直接激活的交换蛋白(EPAC)因其在神经再生、刺激胰岛素释放、控制血管压力和控制其他代谢活动中的功能而受到认可。近年来,许多研究发现,EPAC的亚型EPAC1参与神经炎症的调节,并在疼痛调节中起关键作用,有望成为慢性疼痛的新治疗靶点。本文综述了EPAC1在慢性疼痛中的主要作用。